Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 47

Related Articles by Review for PubMed (Select 10294356)

1.

Status of generic substitution: problematic drug classes reviewed.

Ross MB.

Hosp Formul. 1989 Aug;24(8):441-4, 447-9.

PMID:
10294356
2.
3.

A review of the safety of generic drugs.

Dighe SV.

Transplant Proc. 1999 May;31(3A Suppl):23S-24S. Review.

PMID:
10330955
4.

The debate over substitution policy. Its evolution and scientific basis.

Schwartz LL.

Am J Med. 1985 Aug 23;79(2B):38-44. Review.

PMID:
3898831
5.

Generic substitution: the use of medicinal products containing different salts and implications for safety and efficacy.

Verbeeck RK, Kanfer I, Walker RB.

Eur J Pharm Sci. 2006 May;28(1-2):1-6. Epub 2006 Jan 18. Review.

PMID:
16413762
6.

Generic substitution: issues for problematic drugs.

Henderson JD, Esham RH.

South Med J. 2001 Jan;94(1):16-21. Review. Erratum in: South Med J. 2001 Dec;94(12):1235.

PMID:
11213935
7.

Generic clozapine: a cost-saving alternative to brand name clozapine?

Tse G, Thompson D, Procyshyn RM.

Pharmacoeconomics. 2003;21(1):1-11. Review.

PMID:
12484800
8.

Quality of reporting of bioequivalence trials comparing generic to brand name drugs: a methodological systematic review.

van der Meersch A, Dechartres A, Ravaud P.

PLoS One. 2011;6(8):e23611. doi: 10.1371/journal.pone.0023611. Epub 2011 Aug 17. Review.

9.

Prescribing generic antiepileptic drugs: Issues and concerns for nurse practitioners.

Barrett MW.

J Am Acad Nurse Pract. 2010 Jun;22(6):300-4. doi: 10.1111/j.1745-7599.2010.00511.x. Review.

PMID:
20536627
10.

Generic drugs in dermatology: part II.

Payette M, Grant-Kels JM.

J Am Acad Dermatol. 2012 Mar;66(3):353.e1-15; quiz 367-8. doi: 10.1016/j.jaad.2011.11.945. Review.

PMID:
22342022
11.

The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence.

Duh MS, Cahill KE, Paradis PE, Cremieux PY, Greenberg PE.

Expert Opin Pharmacother. 2009 Oct;10(14):2317-28. doi: 10.1517/14656560903140525. Review.

PMID:
19663636
12.

Therapeutic inequivalence.

Rheinstein PH.

Drug Saf. 1990;5 Suppl 1:114-9. Review.

PMID:
2182054
13.

Therapeutic equivalents in clinical practice.

Benson MD.

Int J Fertil Womens Med. 2001 Mar-Apr;46(2):89-94. Review.

PMID:
11374660
14.

Medical and psychiatric implications of generic drugs.

Diamond BI, Albrecht JW.

Psychopathology. 1987;20 Suppl 1:92-8. Review.

PMID:
3321135
15.

Issues in the use of generic antiarrhythmic drugs.

Reiffel JA.

Curr Opin Cardiol. 2001 Jan;16(1):23-9. Review.

PMID:
11124715
16.

Follow-on biologics: competition in the biopharmaceutical marketplace.

Devine JW, Cline RR, Farley JF.

J Am Pharm Assoc (2003). 2006 Mar-Apr;46(2):193-201; quiz 202-4. Review.

PMID:
16602229
17.

Generic low-molecular-weight heparins: some practical considerations.

Fareed J, Leong WL, Hoppensteadt DA, Jeske WP, Walenga J, Wahi R, Bick RL.

Semin Thromb Hemost. 2004 Dec;30(6):703-13. Review.

PMID:
15630677
18.

Economics and structure of the generic pharmaceutical industry.

Kirking DM, Ascione FJ, Gaither CA, Welage LS.

J Am Pharm Assoc (Wash). 2001 Jul-Aug;41(4):578-84. Review.

PMID:
11486984
19.

United States Food and Drug Administration requirements for approval of generic drug products.

Meyer MC.

J Clin Psychiatry. 2001;62 Suppl 5:4-9; discussion 23-4. Review.

PMID:
11305846
20.

Generic and alternative brand-name pharmaceutical equivalents: select with caution.

Hendeles L, Hochhaus G, Kazerounian S.

Am J Hosp Pharm. 1993 Feb;50(2):323-9. Review. No abstract available. Erratum in: Am J Hosp Pharm 1993 May;50(5):913.

PMID:
8480793
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk